Mark J. Ratain to Biomedical Research
This is a "connection" page, showing publications Mark J. Ratain has written about Biomedical Research.
Connection Strength
1.615
-
Do patent applications and Cooperative Research and Development Agreements between the National Cancer Institute and industry serve the public interest? Nat Biotechnol. 2023 Nov; 41(11):1517-1519.
Score: 0.659
-
Institutional Profile: University of Chicago Center for Personalized Therapeutics: research, education and implementation science. Pharmacogenomics. 2013 Sep; 14(12):1383-7.
Score: 0.326
-
Nonprofit biomedical companies. Clin Pharmacol Ther. 2008 Aug; 84(2):194-7.
Score: 0.229
-
Critical importance of correctly defining and reporting secondary endpoints when assessing the ethics of research biopsies. Clin Trials. 2024 Oct; 21(5):650-656.
Score: 0.170
-
Conflict-of-interest policies. N Engl J Med. 2001 Mar 29; 344(13):1018.
Score: 0.138
-
Impact of the 2010 Consensus Recommendations of the Clinical Trial Design Task Force of the NCI Investigational Drug Steering Committee. Clin Cancer Res. 2015 Nov 15; 21(22):5057-63.
Score: 0.095